logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 6
  • 1
    Foerch, Patrik, Dr
    Born in December 1971
    Individual (3 offsprings)
    Officer
    2026-07-01 ~ now
    OF - Director → CIF 0
  • 2
    Johnson, Kieran Roy Darren
    Born in May 1969
    Individual (10 offsprings)
    Officer
    2026-07-01 ~ now
    OF - Director → CIF 0
  • 3
    Nakafuji, Mariko
    Born in December 1985
    Individual (4 offsprings)
    Officer
    2025-11-07 ~ now
    OF - Director → CIF 0
    Nakafuji, Mariko
    Individual (4 offsprings)
    Officer
    2025-11-07 ~ now
    OF - Secretary → CIF 0
  • 4
    Cargill, Christopher Robert
    Born in January 1984
    Individual (5 offsprings)
    Officer
    2025-11-07 ~ now
    OF - Director → CIF 0
  • 5
    NXERA PHARMA CO., LTD.
    - now FC024112
    SOSEI GROUP CORPORATION - 2024-04-17
    SOSEI CO., LTD. - 2002-10-09
    Midtown East 7f, 9-7-2 Akasaka, Minato-ku, Tokyo, Japan
    Active Corporate (25 parents, 5 offsprings)
    Person with significant control
    2025-11-07 ~ 2026-06-01
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
  • 6
    NXERA PHARMA UK SERVICES LIMITED
    16789357
    First Floor Burleigh On The Strand 355-359, Strand, London, United Kingdom
    Active Corporate (5 parents, 1 offspring)
    Person with significant control
    2026-06-01 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

NXERA PHARMA AQ LIMITED

Period: 2026-07-01 ~ now
Company number: 16840517
Registered names
NXERA PHARMA AQ LIMITED - now
NXERA AQ LIMITED - 2026-07-01
Recent Standard Industrial Classification
62012 - Business And Domestic Software Development
72110 - Research And Experimental Development On Biotechnology

  • NXERA PHARMA AQ LIMITED
    Info
    NXERA AQ LIMITED - 2026-07-01
    Registered number 16840517
    First Floor Burleigh On The Strand, 355-359 Strand, London WC2R 0HS
    PRIVATE LIMITED COMPANY incorporated on 2025-11-07 (9 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-11-12
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.